Based on ROC curve analysis, free/total PSA in serum showed a relatively high sensitivity and specificity to distinguish BPH and PCa (Figure 4D), which was consistent with a previous report showing that PSA is a biomarker of PCa. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.